Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer (RAD 1702)
Sponsor: University of Alabama at Birmingham
This EARLY_PHASE1 trial investigates Locally Advanced Head and Neck Cancer and is currently completed. University of Alabama at Birmingham leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Sep 2021 — Jul 2024 [monthly]
Completed EARLY_PHASE1
Status: Active Not Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jan 2020 — Jan 2021 [monthly]
Active Not Recruiting EARLY_PHASE1
▶ Show 3 earlier versions
-
Jun 2019 — Jan 2020 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Nov 2017 — Jun 2018 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Alabama at Birmingham
For direct contact, visit the study record on ClinicalTrials.gov .